Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Grigoleit

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Plos One|October 1, 2019
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapyBenjamin Faist, Fabian Schlott, Christian Stemberger, et al.
Annals of Hematology|April 18, 2019
Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patientsP Lamby, D Wolff, S Mielke, et al.
Bone Marrow Transplantation|November 8, 2016
Evidence for CD19B-CD8T cell interactions in blood and tissues from patients with GvHDS Deola, C Cugno, P Comoli, et al.
Blood|May 24, 2014
Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapyChristian Stemberger, Patricia Graef, Marcus Odendahl, et al.
Journal of Translational Medicine|April 23, 2020
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytesM J Steinhardt, E Wiercinska, M Pham, et al.
Blood Neoplasia|June 2, 2025
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trialUlrich Dührsen, Andreas Bockisch, Bernd Hertenstein, et al.
Leukemia|January 17, 2017
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCTM Neuenhahn, J Albrecht, M Odendahl, et al.
American Journal of Hematology|May 26, 2022
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trialDietrich W Beelen, Matthias Stelljes, Péter Reményi, et al.
Leukemia|August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter surveyR Zeiser, A Burchert, C Lengerke, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Plos One|October 1, 2019
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapyBenjamin Faist, Fabian Schlott, Christian Stemberger, et al.
Annals of Hematology|April 18, 2019
Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patientsP Lamby, D Wolff, S Mielke, et al.
Bone Marrow Transplantation|November 8, 2016
Evidence for CD19B-CD8T cell interactions in blood and tissues from patients with GvHDS Deola, C Cugno, P Comoli, et al.
Blood|May 24, 2014
Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapyChristian Stemberger, Patricia Graef, Marcus Odendahl, et al.
Journal of Translational Medicine|April 23, 2020
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytesM J Steinhardt, E Wiercinska, M Pham, et al.
Blood Neoplasia|June 2, 2025
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trialUlrich Dührsen, Andreas Bockisch, Bernd Hertenstein, et al.
Leukemia|January 17, 2017
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCTM Neuenhahn, J Albrecht, M Odendahl, et al.
American Journal of Hematology|May 26, 2022
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trialDietrich W Beelen, Matthias Stelljes, Péter Reményi, et al.
Leukemia|August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter surveyR Zeiser, A Burchert, C Lengerke, et al.
Pageof 3